Contact
Please use this form to send email to PR contact of this press release:
Alanis Therapeutics Announces Collaboration with Blood Cancer United’s Beat AML to Advance Therapeutic for MDS/AML
TO:
Robert S Goodenow
Alanis Therapeutics
+1 949-291-9018